Is autofluorescence bronchoscopy needed to diagnose early bronchogenic carcinoma? Con: Autofluorescence bronchoscopy

Journal of Bronchology

Volumn 10, Issue 1, 2003, Pages 70-74

  Mehta, Atul C ^a   Gildea, Thomas R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOFLUORESCENCE; BRONCHOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; LUNG CARCINOMA; PRIORITY JOURNAL; REVIEW; STANDARD;

EID: 0037284555     PISSN: 10708030     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128594-200301000-00016     Document Type: Review

References (22)

1. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer 1996;77:1947-55.
2. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.
3. Naruke T, Tsuchiya R, Kondo H, et al. Implications of staging in lung cancer. Chest 1997;112(4 Suppl):242S-8S.
4. Bechtel JJ, Kelley WR, Petty TL, et al. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch Intern Med 1994;154:975-80.
5. Strauss G, Decamp M, DiBiccaro E. Lung cancer diagnosis is being made with increasing frequency in former cigarette smokers [abstract]. Proc Am Soc Clin Oncol 1995;14:362.
6. Wistuba II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-73.
7. Risse EK, Vooijs GP, van't Hof MA. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta Cytol 1988;32: 629-34.
8. Frost JK, Ball WC Jr, Levin ML, et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biologic effects of exposure. J Occup Med 1986;28:692-703.
9. Band PR, Feldstein M, Saccomanno G. Reversibility of bronchial marked atypia: implication for chemoprevention. Cancer Detect Prev 1986;9:157-60.
10. Venmans BJ, van boxem TJ, Smit EF, et al. Outcome of bronchial carcinoma in situ. Chest 2000;117:1572-6.
11. Thiberville L, Metayer J, Raspaud C. A prospective short term follow-up study of 59 severe dysplasias and carcinoma in situ of the bronchus using auto fluorescence endoscopy [abstract]. Eur Respir J 1997;10(Suppl 25):425S.
12. Bota S, Auliac JB, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 2001;164:1688-93.
13. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998;113:696-702.
14. Khanavkar B. Autofluorescence bronchoscopy. J Bronchol 2000;7:60-6.
15. Kurie JM, Lee JS, Morice RC, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1998;90:991-5.
16. Venmans BJ, et al. Results of fluorescence bronchoscopy in the detection of preinvasive bronchial neoplasia: influence of observer variability in histopathologic reporting of bronchial biopsy specimens [abstract]. Am J Respir Crit Care Med 1999;159:A710.
17. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
18. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595-602.
19. Ihde DC, Lippman S. Intervention approaches in early lung cancer and premalignant disease: breakout group report. Cancer Res 1992;52(9 Suppl):2767s-8s.
20. Sackett DL, Holland WW. Controversy in the detection of disease. Lancet 1975;2(7930):357-9.
21. Petty TL. It's time to pick the low-hanging fruit [editorial]. Chest 2000;117:1-2.
22. Carney DN. Lung cancer - time to move on from chemotherapy [editorial]. N Engl J Med 2002;346:126-8.